The U.S. government is investing $3.2 billion to develop antiviral pills for Covid-19, the New York Times reports, citing an announcement from the Department of Health and Human Services.
- Some pills could be available by the end of the year
- Government considering AT-527, developed by
- Atea shares up Thursday as much as 13.6%
- Drug created by
Pfizerscientists on government’s radar
- Antiviral Program for Pandemics to support research for new drugs, not just for the coronavirus
To contact the reporter on this story:
To contact the editors responsible for this ...